skip to nav skip to content

Video Library

Medical Minute

Medical Minute Thursday, Jun 17, 2010 Tasigna® Only Treatment To Surpass Gleevec In Slowing Disease Progression For Newly Diagnosed Cml Patients Longer-term, 18-month, data from a pivotal study being presented at the 46th Annual Meeting of the A

  • Print

This site uses Facebook comments to make it easier for you to contribute. If you see a comment you would like to flag for spam or abuse, click the "x" in the upper right of it. By posting, you agree to our Terms of Use.

More Videos

All Videos

FOX 4 News